Retigabine add-on for refractory partial-onset seizures

This review has been withdrawn.

The reason for withdrawal and previous versions are archived and accessible within the withdrawn record in the Cochrane Library.

Health topics:

Neurology > Epilepsy > Drugs for broad populations

Published:

25 June 2021

Authors:

Huda S, Shukralla A, Marson AG

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Huda S, Shukralla A, Marson AG. Retigabine add-on for refractory partial-onset seizures (Protocol). Cochrane Database of Systematic Reviews 2021, Issue 6. Art. No.: CD009368. DOI: 10.1002/14651858.CD009368.pub2.